The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Increases speed to market for drug developers working on nucleic acid therapeutics
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate (ADC)
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
This facility marks a significant milestone in transforming the global food industr
Subscribe To Our Newsletter & Stay Updated
